REVIEW(S)Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials
REFERENCES (48)
Advances in upper airway diseases and allergen immunotherapy
J Allergy Clin Immunol
(2003)- et al.
Efficacy and safety of sublingual immunotherapy
Ann Allergy Asthma Immunol
(2004) Noninjection routes for immunotherapy
J Allergy Clin Immunol
(2003)- et al.
Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis
J Allergy Clin Immunol
(2004) - et al.
Assessing the quality of reports of randomized clinical trials: is blinding necessary?
Control Clin Trials
(1996) - et al.
Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists
Control Clin Trials
(1995) - et al.
Meta-analysis in clinical trials
Control Clin Trials
(1986) - et al.
Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica in children with allergic rhinoconjunctivitis
J Allergy Clin Immunol
(1999) - et al.
Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years
Ann Allergy Asthma Immunol
(2005) - et al.
Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-Study)
J Allergy Clin Immunol
(2002)
WHO position paper: allergen immunotherapy: therapeutic vaccines for allergic diseases
Allergy
(1998)
The WHO ARIA (Allergic Rhinitis and Its Impact on Asthma) initiative
Chem Immunol Allergy
(2003)
Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study
Allergy
(2004)
Sublingual immunotherapy: an update
Curr Opin Allergy Clin Immunol
(2004)
Sublingual immunotherapy in pediatric patients: beyond clinical efficacy
Curr Opin Allergy Clin Immunol
(2005)
The safety of sublingual-swallow immunotherapy: an analysis of published studies
Clin Exp Allergy
(2005)
Sublingual immunotherapy: from proven prevention to putative rapid relief of allergic symptoms
Allergy
(2005)
Immunotherapy: position paper of the European Academy of Allergy and Clinical Immunology
Allergy
(1993)
Post-marketing surveillance study on the safety of sublingual immunotherapy in children
Allergy
(1999)
Safety of sublingual immunotherapy in adults: a post marketing surveillance study
Allergy
(2001)
Clinical practice: allergic rhinitis
N Engl J Med
(2005)
Sublingual immuno-therapy for allergic rhinitis: systematic review and meta-analysis
Allergy
(2005)
Efficacy of sublingual allergen vaccination for respiratory allergy in children: conclusions from one meta-analysis
J Invest Allergol Clin Immunol
(2005)
Immunomodulation during sublingual therapy in allergic children
Pediatr Allergy Immunol
(2003)
Cited by (0)
Potential financial conflicts of interest: Dr Giorgio Walter Canonica and Dr G Passalacqua report having received research grants and lecture fees from the following: Alk-Abello, Anallergo, Allergy Therapeutics, A. Menarini, Almirall, Altana, AstraZeneca, Boehringer Ingelheim, Chiesi Farmaceutici, Genentech, Gentili, Glaxo Smith Kline, Lofarma, Merck Sharp & Dome, Novartis, Pfizer, Schering Plough, Stallergenes, and UCB Pharma.
Copyright © 2006 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.